Global Noninvasive Cancer Diagnostics Technology Market Research Report 2024(Status and Outlook)

Global Noninvasive Cancer Diagnostics Technology Market Research Report 2024(Status and Outlook)



Report Overview:

Noninvasive Cancer Diagnostics Technology is a process for the detection of disease through minimal incisions into the body. Noninvasive cancer diagnostic technologies provide fast and convenient procedures for noninvasive early detection of cancer and provide a valuable aid to the clinician and increased comfort to the patient.Noninvasive Cancer Diagnosis Technologies are used to identify breast, lung, blood, and other cancers.

The Global Noninvasive Cancer Diagnostics Technology Market Size was estimated at USD 3787.96 million in 2023 and is projected to reach USD 5781.01 million by 2029, exhibiting a CAGR of 7.30% during the forecast period.

This report provides a deep insight into the global Noninvasive Cancer Diagnostics Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Noninvasive Cancer Diagnostics Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Noninvasive Cancer Diagnostics Technology market in any manner.

Global Noninvasive Cancer Diagnostics Technology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Precision Therapeutics

Affymetrix Inc.

Gen-Probe Incorporated

AVIVA Biosciences Corporation

A&G Pharmaceutical

BIOVIEW Inc.

Quest Diagnostics Incorporated

Digene Corporation

Laboratory Corporation of America Holdings.

GRAIL, Inc

Guardant Health, Inc

Genomic Health, Inc.

Illumina, Inc

NeoGenomics Laboratories, Inc.

Biocept, Inc

Market Segmentation (by Type)

Immunoassays

Molecular Diagnostics

Clinical Chemistry

Others

Market Segmentation (by Application)

Medical Device Manufacturing Company

Oncology Laboratories

Government and Private Research Institutions

Academic Institutions and Pharmaceutical Companies

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Noninvasive Cancer Diagnostics Technology Market

Overview of the regional outlook of the Noninvasive Cancer Diagnostics Technology Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Noninvasive Cancer Diagnostics Technology Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Noninvasive Cancer Diagnostics Technology
1.2 Key Market Segments
1.2.1 Noninvasive Cancer Diagnostics Technology Segment by Type
1.2.2 Noninvasive Cancer Diagnostics Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Noninvasive Cancer Diagnostics Technology Market Overview
2.1 Global Market Overview
2.1.1 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Noninvasive Cancer Diagnostics Technology Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Noninvasive Cancer Diagnostics Technology Market Competitive Landscape
3.1 Global Noninvasive Cancer Diagnostics Technology Sales by Manufacturers (2019-2024)
3.2 Global Noninvasive Cancer Diagnostics Technology Revenue Market Share by Manufacturers (2019-2024)
3.3 Noninvasive Cancer Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Noninvasive Cancer Diagnostics Technology Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Noninvasive Cancer Diagnostics Technology Sales Sites, Area Served, Product Type
3.6 Noninvasive Cancer Diagnostics Technology Market Competitive Situation and Trends
3.6.1 Noninvasive Cancer Diagnostics Technology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Noninvasive Cancer Diagnostics Technology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Noninvasive Cancer Diagnostics Technology Industry Chain Analysis
4.1 Noninvasive Cancer Diagnostics Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Noninvasive Cancer Diagnostics Technology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Noninvasive Cancer Diagnostics Technology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Type (2019-2024)
6.3 Global Noninvasive Cancer Diagnostics Technology Market Size Market Share by Type (2019-2024)
6.4 Global Noninvasive Cancer Diagnostics Technology Price by Type (2019-2024)
7 Noninvasive Cancer Diagnostics Technology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Noninvasive Cancer Diagnostics Technology Market Sales by Application (2019-2024)
7.3 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) by Application (2019-2024)
7.4 Global Noninvasive Cancer Diagnostics Technology Sales Growth Rate by Application (2019-2024)
8 Noninvasive Cancer Diagnostics Technology Market Segmentation by Region
8.1 Global Noninvasive Cancer Diagnostics Technology Sales by Region
8.1.1 Global Noninvasive Cancer Diagnostics Technology Sales by Region
8.1.2 Global Noninvasive Cancer Diagnostics Technology Sales Market Share by Region
8.2 North America
8.2.1 North America Noninvasive Cancer Diagnostics Technology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Noninvasive Cancer Diagnostics Technology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Noninvasive Cancer Diagnostics Technology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Noninvasive Cancer Diagnostics Technology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Noninvasive Cancer Diagnostics Technology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Precision Therapeutics
9.1.1 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Basic Information
9.1.2 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Overview
9.1.3 Precision Therapeutics Noninvasive Cancer Diagnostics Technology Product Market Performance
9.1.4 Precision Therapeutics Business Overview
9.1.5 Precision Therapeutics Noninvasive Cancer Diagnostics Technology SWOT Analysis
9.1.6 Precision Therapeutics Recent Developments
9.2 Affymetrix Inc.
9.2.1 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Basic Information
9.2.2 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Overview
9.2.3 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
9.2.4 Affymetrix Inc. Business Overview
9.2.5 Affymetrix Inc. Noninvasive Cancer Diagnostics Technology SWOT Analysis
9.2.6 Affymetrix Inc. Recent Developments
9.3 Gen-Probe Incorporated
9.3.1 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
9.3.2 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
9.3.3 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology Product Market Performance
9.3.4 Gen-Probe Incorporated Noninvasive Cancer Diagnostics Technology SWOT Analysis
9.3.5 Gen-Probe Incorporated Business Overview
9.3.6 Gen-Probe Incorporated Recent Developments
9.4 AVIVA Biosciences Corporation
9.4.1 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Basic Information
9.4.2 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Overview
9.4.3 AVIVA Biosciences Corporation Noninvasive Cancer Diagnostics Technology Product Market Performance
9.4.4 AVIVA Biosciences Corporation Business Overview
9.4.5 AVIVA Biosciences Corporation Recent Developments
9.5 AandG Pharmaceutical
9.5.1 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Basic Information
9.5.2 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Overview
9.5.3 AandG Pharmaceutical Noninvasive Cancer Diagnostics Technology Product Market Performance
9.5.4 AandG Pharmaceutical Business Overview
9.5.5 AandG Pharmaceutical Recent Developments
9.6 BIOVIEW Inc.
9.6.1 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Basic Information
9.6.2 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Overview
9.6.3 BIOVIEW Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
9.6.4 BIOVIEW Inc. Business Overview
9.6.5 BIOVIEW Inc. Recent Developments
9.7 Quest Diagnostics Incorporated
9.7.1 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Basic Information
9.7.2 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Overview
9.7.3 Quest Diagnostics Incorporated Noninvasive Cancer Diagnostics Technology Product Market Performance
9.7.4 Quest Diagnostics Incorporated Business Overview
9.7.5 Quest Diagnostics Incorporated Recent Developments
9.8 Digene Corporation
9.8.1 Digene Corporation Noninvasive Cancer Diagnostics Technology Basic Information
9.8.2 Digene Corporation Noninvasive Cancer Diagnostics Technology Product Overview
9.8.3 Digene Corporation Noninvasive Cancer Diagnostics Technology Product Market Performance
9.8.4 Digene Corporation Business Overview
9.8.5 Digene Corporation Recent Developments
9.9 Laboratory Corporation of America Holdings.
9.9.1 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Basic Information
9.9.2 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Overview
9.9.3 Laboratory Corporation of America Holdings. Noninvasive Cancer Diagnostics Technology Product Market Performance
9.9.4 Laboratory Corporation of America Holdings. Business Overview
9.9.5 Laboratory Corporation of America Holdings. Recent Developments
9.10 GRAIL, Inc
9.10.1 GRAIL, Inc Noninvasive Cancer Diagnostics Technology Basic Information
9.10.2 GRAIL, Inc Noninvasive Cancer Diagnostics Technology Product Overview
9.10.3 GRAIL, Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
9.10.4 GRAIL, Inc Business Overview
9.10.5 GRAIL, Inc Recent Developments
9.11 Guardant Health, Inc
9.11.1 Guardant Health, Inc Noninvasive Cancer Diagnostics Technology Basic Information
9.11.2 Guardant Health, Inc Noninvasive Cancer Diagnostics Technology Product Overview
9.11.3 Guardant Health, Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
9.11.4 Guardant Health, Inc Business Overview
9.11.5 Guardant Health, Inc Recent Developments
9.12 Genomic Health, Inc.
9.12.1 Genomic Health, Inc. Noninvasive Cancer Diagnostics Technology Basic Information
9.12.2 Genomic Health, Inc. Noninvasive Cancer Diagnostics Technology Product Overview
9.12.3 Genomic Health, Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
9.12.4 Genomic Health, Inc. Business Overview
9.12.5 Genomic Health, Inc. Recent Developments
9.13 Illumina, Inc
9.13.1 Illumina, Inc Noninvasive Cancer Diagnostics Technology Basic Information
9.13.2 Illumina, Inc Noninvasive Cancer Diagnostics Technology Product Overview
9.13.3 Illumina, Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
9.13.4 Illumina, Inc Business Overview
9.13.5 Illumina, Inc Recent Developments
9.14 NeoGenomics Laboratories, Inc.
9.14.1 NeoGenomics Laboratories, Inc. Noninvasive Cancer Diagnostics Technology Basic Information
9.14.2 NeoGenomics Laboratories, Inc. Noninvasive Cancer Diagnostics Technology Product Overview
9.14.3 NeoGenomics Laboratories, Inc. Noninvasive Cancer Diagnostics Technology Product Market Performance
9.14.4 NeoGenomics Laboratories, Inc. Business Overview
9.14.5 NeoGenomics Laboratories, Inc. Recent Developments
9.15 Biocept, Inc
9.15.1 Biocept, Inc Noninvasive Cancer Diagnostics Technology Basic Information
9.15.2 Biocept, Inc Noninvasive Cancer Diagnostics Technology Product Overview
9.15.3 Biocept, Inc Noninvasive Cancer Diagnostics Technology Product Market Performance
9.15.4 Biocept, Inc Business Overview
9.15.5 Biocept, Inc Recent Developments
10 Noninvasive Cancer Diagnostics Technology Market Forecast by Region
10.1 Global Noninvasive Cancer Diagnostics Technology Market Size Forecast
10.2 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country
10.2.3 Asia Pacific Noninvasive Cancer Diagnostics Technology Market Size Forecast by Region
10.2.4 South America Noninvasive Cancer Diagnostics Technology Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Noninvasive Cancer Diagnostics Technology by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Noninvasive Cancer Diagnostics Technology by Type (2025-2030)
11.1.2 Global Noninvasive Cancer Diagnostics Technology Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Noninvasive Cancer Diagnostics Technology by Type (2025-2030)
11.2 Global Noninvasive Cancer Diagnostics Technology Market Forecast by Application (2025-2030)
11.2.1 Global Noninvasive Cancer Diagnostics Technology Sales (K Units) Forecast by Application
11.2.2 Global Noninvasive Cancer Diagnostics Technology Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings